Category: Labs’

U.S. Lab’s Dire Warning Puts Surging Stock Market at Risk
, ,

U.S. Lab’s Dire Warning Puts Surging Stock Market at Risk

Testing capacity is nearly impossible to increase as autumn approaches, the biggest laboratory in the U.S. says. Flu season could make the pandemic harder to get under control. Vaccine progress may not be enough to sustain the stock market recovery in the short-term. From Moderna in the U.S. to Oxford in the U.K., the race…

Read More